S.1681: A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

About This Bill

  • This bill was introduced in the 115th Congress
  • This bill is primarily about health
  • Introduced July 31, 2017
  • Latest Major Action July 31, 2017

Bill Version

Bill Actions

Date Description
July 31, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
July 31, 2017

Introduced in the Senate by Bernard Sanders (ID-Vt.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page